Johnson & Johnson says its COVID-19 vaccine strong against Delta variant in new study

Johnson & Johnson says its COVID-19 vaccine strong against Delta variant in new study

SEMrush
The healthcare company said that its vaccine was 85 per cent effective and could also help prevent hospitalization and death against the highly transmissible strain.
[automaticbacklinks]